Nova Patents
ZA201106907B

Anti-fcrh5 antibodies and immunoconjugates and methods of use

Abstract

The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Term

5 yearsleft in the term

Expires 21 September 2031.

  1. Priority
  2. Filed
  3. Granted
  4. Today
  5. Expires

39 members in 25 offices

This recordMember, by publication datePriority claim15 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
61211695United States of America–
21169509United States of AmericaP
61166217United States of America–
16621709United States of AmericaP
61266972United States of America–
26697209United States of AmericaP
2010029516United States of AmericaW

Members39

Family members, oldest first
DocumentOfficeKind
US2010260748A1United States of AmericaA1
CA2757382A1CanadaA1
WO2010120561A1World Intellectual Property Organization (WIPO)A1
TW201038286ATaiwan Province of ChinaA
AR076029A1ArgentinaA1
MX2011010264AMexicoA
MX2011010264AMexicoA
AU2010236787A1AustraliaA1
SG174992A1SingaporeA1
CR20110558ACosta RicaA
CR20110558ACosta RicaA
IL215402A0IsraelA0
ECSP11011436AEcuadorA
ECSP11011436AEcuadorA
EP2414399A1European Patent Office (EPO)A1
CL2011002417A1ChileA1
CO6430468A2ColombiaA2
MA33256B1MoroccoB1
CN102471380AChinaA
KR20120057565ARepublic of KoreaA
PE20120878A1PeruA1
JP2012522512AJapanA
ZA201106907BThis recordSouth AfricaB
HK1171236AHong Kong, ChinaA
HK1171236A1Hong Kong, ChinaA1
US2013089555A1United States of AmericaA1
RU2011144141ARussian FederationA
US8466260B2United States of AmericaB2
NZ595574ANew ZealandA
US8617559B2United States of AmericaB2
UA104460C2UkraineC2
US2014106374A1United States of AmericaA1
CN102471380BChinaB
BRPI1012676A2BrazilA2
JP2016063812AJapanA
US9360484B2United States of AmericaB2
RU2587621C2Russian FederationC2
JP6132548B2JapanB2
JP2017160206AJapanA